The 41 references in paper G. Gorodetskaya I., E. Sokova A., O. Muslimova V., T. Aleksandrova V., I. Mazerkina A., S. Rudnev G., Г. Городецкая И., Е. Сокова А., О. Муслимова В., Т. Александрова В., И. Мазеркина А., С. Руднев Г. (2018) “Взаимозаменяемость препаратов левотироксина // Interchangeability of levothyroxine sodium tablets” / spz:neicon:vedomostincesmp:y:2017:i:1:p:33-40

1
Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N. Thyroid Na+/I–symporter. Mechanism, stoichiometry, and specificity. J Biol Chem.1997; 272: 27230–8.
(check this in PDF content)
2
De la Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiological Reviews 2000; 80(3): 1083–105.
(check this in PDF content)
3
Boron WF. Medical Physiology: A Cellular And Molecular Approach. Elsevier/Saunders; 2003.
(check this in PDF content)
4
Dunn JT, Ray SC. Changes in the structure of thyroglobulin following the administration of thyroid-stimulating hormone. J Biol Chem. 1975; 250: 5801–7.
(check this in PDF content)
5
Greer MA, Grimm Y, Studer H. Qualitative changes in the secretion of thyroid hormones induced by iodine deficiency. Endocrinology 1968; 83: 1193–8.
(check this in PDF content)
6
Laurberg P. Mechanisms governing the relative proportions of thyroxine and 3,5,3-triiodothyronine in thyroid secretion. Metab Clin Exp. 1984; 33: 379–92.
(check this in PDF content)
7
Leonard JL, Kohrle J. Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD, eds. The Thyroid. 8th ed. Lippincott, Philadelphia; 2000.
(check this in PDF content)
8
Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009; 94(5): 1623–9.
(check this in PDF content)
9
Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, et al. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab. 2008; 93(8): 3075–81.
(check this in PDF content)
10
Mendel CM. The Free Hormone Hypothesis: A Physiologically Based Mathematical Model. Endocrine reviews 1989; 10(3): 232–74.
(check this in PDF content)
11
Wilber JF, Xu AH. The thyrotropin-releasing hormone gene: cloning, characterization, and transcriptional regulation in the central nervous system, heart, and testis. Thyroid 1998; (8): 897–901.
(check this in PDF content)
12
Zakharenko RV. Clinical aspects of thyroid disease in patients with cardiac pathology. Dalnevostochny meditsinskiy zhurnal 2010; (3): 18–22 (in Russian).
(check this in PDF content)
13
Veintraub BV, ed. Molecular endocrinology. Fundamental study and it’s reflection in the clinic. Moscow: Meditsina; 2003 (in Russian).
(check this in PDF content)
14
Pearce SHS, Brabant G, Duntas L, Monzani F, Peeters R, Razvi S, Wemeau JL. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J 2013; 2(4): 215–28.
(check this in PDF content)
15
Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ 2012; 345.
(check this in PDF content)
16
Tsareva YuO. Features of daily fluctuations of thyroid hormones in patients with cardiovasculardisease. BulletenmeditsinskihInternetkonferentsiy 2014; 4(3): 232. Available from: https://goo.gl/783enU (in Russian).
(check this in PDF content)
17
Nekrasova TA, Strongin LG, Ledentsova OV, Kazakova LV. The relationship between TTG levels and some of the factors of cardiovascular risk in patients with autoimmune thyroiditis and subclinical hypothyroidism. Klinicheskaya i eksperimentalnaya tireoidologiya 2014; (2): 16–22 (in Russian).
(check this in PDF content)
18
Bartáková J, Potlukova E, Rogalewicz V, Fait T, Schöndorfova D, Telivcka Z, et al.Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves thesubsequent pregnancy rate. BMC Pregnancy Childbirth 2013; 13: 217.
(check this in PDF content)
19
Peroni E, Vigone MC, Mora S, Bassi LA, Pozzi C, Passoni A, Weber G. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Hormone Research in Paediatrics 2013; 81(1): 50–4.
(check this in PDF content)
20
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18(6): 988–1028.
(check this in PDF content)
21
Gkotsina M, Michalaki M, Mamali I, Markantes G, Sakellaropoulos GC, Kalfarentzos F, et al. Improvedlevothyroxine pharmacokinetics after bariatric surgery. Thyroid 2013; 23: 414–9.
(check this in PDF content)
22
Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 1977; 26: 1–8.
(check this in PDF content)
23
Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, et al. Thyroxine in goiter, Helicobacter pilori infection, and chronic gastritis. N Engl J Med 2006; 354: 1787–95.
(check this in PDF content)
24
Hadithi M, de Boer H, Meijer JW, Willekens F, Kerckhaert JA, Heijmans R, et al. Coeliac disease in Dutch patients with Hashimoto’s thyroditis and vice versa. World J Gastroenterol. 2007; 13: 1715–22.
(check this in PDF content)
25
Muñoz-Torres M, Varsavsky M, Alonso G. Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid 2006; 16: 1171–3.
(check this in PDF content)
26
Ladas S, Papanikos J, Arapakis G. Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 1982; 23: 968–73.
(check this in PDF content)
27
Belmer SV, Mukhina YuG, Chubarova AI, et al. Lactose intolerance in children and adults. Voprosy detskoy dietologii 2004; 2(1): 101–3 (in Russian).
(check this in PDF content)
28
Eadala P, Waud JP, Matthews SB, Green JT, Campell AK, Quantifying the «hidden» lactose in drugs used for the treatment of gastrointestinal conditions. Aliment Pharmacol Ther. 2009; 29: 677–87.
(check this in PDF content)
29
United States Pharmacopoeia. Available from: http:// www.usp.org.
(check this in PDF content)
30
Patel H, Stalcup A, Dansereau R, Sakr A. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. Int J Pharm. 2003; 264(1–2): 35–43.
(check this in PDF content)
31
Emshanova SV, Sadchikova NP, Zuev AP. Drug particle shape and size control: A necessary factor for high-quality drug production. Pharmaceutical Chemistry Journal 2007; 41(1): 40–9.
(check this in PDF content)
32
Emshanova SV. Ensuring the quality of domestic medical products (technology optimization and improvement of tablet dosage forms standardization). Dr. Pharm. Sci [thesis]. Moscow; 2007 (in Russian).
(check this in PDF content)
33
State Register of medicines. Available from: http:// grls.rosminzdrav.ru/grls.aspx.
(check this in PDF content)
34
Fadeev VV, Morgunova TB. Topical issues of substitution treatment of hypothyroidism. Farmateka 2007; (11): 36–40 (in Russian).
(check this in PDF content)
35
ApprovedDrug Products with Therapeutic Equivalence Evaluations. 37th ed. 2017. Available from: https:// goo.gl/YDrmMM.
(check this in PDF content)
36
American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists. Joint statement on the U. S. Food and Drug Administration’s decision regarding bioequivalence of levothyroxine sodium. Thyroid 2004; 14: 486.
(check this in PDF content)
37
Wiersinga WM. Adult hypothyroidism. In: Endotext. 2014.
(check this in PDF content)
38
State Register of medicines. Available from: http:// grls.rosminzdrav.ru/grls.aspx.
(check this in PDF content)
39
Demidova MA. The problem of interchangeability of L-thyroxine medicines. Effektivnaya farmakoterapiya 2013; 2(22): 8–12 (in Russian). Available from: https:// goo.gl/B1gJxy.
(check this in PDF content)
40
Madiyarova MSh, Morgunova TB, Fadeyev VV. Treatment of primary hypothyroidism: unresolved issues. Klinicheskaya i eksperimentalnaya tireoidologiya 2015; 11(1): 22–34 (in Russian).
(check this in PDF content)
41
Melnichenko GA, Fadeev VV, Proskurina IA, Bogdanov AN, Gorodetsky VV, Gorodetskaya GI. Guidelines for conducting clinical trials of medicinal products used in the thyroid gland pathology. In: Mironov AN, ed. Guide for conducting clinical trials of medicinal products. Moscow: Grif i K; 2012. P. 163–76 (in Russian).
(check this in PDF content)